We are live on
!
Find out more
SL
Siren LLC Portfolio holdings
AUM
$3.61B
1-Year Est. Return
203.3%
This Fund
S&P 500
This Quarter
Est. Return
+22.99%
1 Year Est. Return
+203.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2B
AUM Growth
–
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
97.94%
Top 10 Holdings %
Top 10 Hldgs %
41.25%
Holding
112
New
112
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kymera Therapeutics
KYMR
|
+$131M |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$101M |
| 3 |
Scholar Rock
SRRK
|
+$98.9M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$80.3M |
| 5 |
BCAX
Bicara Therapeutics
BCAX
|
+$78.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.5% |
| 2 | Technology | 2.87% |
| 3 | Communication Services | 1.83% |
| 4 | Consumer Discretionary | 0.77% |
| 5 | Real Estate | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ovid Therapeutics
OVID
$491M
| $3.36M | 0.17% |
+2,850,000
| New | +$2.98M |
|
77
Regenxbio
RGNX
$708M
| $2.98M | 0.15% |
+284,000
| New | +$3.46M |
|
78
New Oriental
EDU
$8.98B
| $2.92M | 0.15% |
+38,500
| New | +$2.64M |
|
79
Qualcomm
QCOM
$176B
| $2.55M | 0.13% |
+15,000
| New | +$2.65M |
|
|
HOOK
80
DELISTED
HOOKIPA Pharma
HOOK
| $2.44M | 0.12% |
+566,640
| New | +$2.99M |
|
|
TRML
81
DELISTED
Tourmaline Bio
TRML
| $2.35M | 0.12% |
+91,426
| New | +$1.53M |
|
82
CALL
PayPal
PYPL
$50.5B
| $2.03M | 0.1% |
+26,000
| New | +$1.74M |
|
83
Sagimet Biosciences
SGMT
$559M
| $2.01M | 0.1% |
+724,771
| New | +$2.23M |
|
84
Procore
PCOR
$8.67B
| $1.99M | 0.1% |
+32,300
| New | +$1.98M |
|
85
KE Holdings
BEKE
$18.8B
| $1.99M | 0.1% |
+100,000
| New | +$1.48M |
|
86
Visa
V
$677B
| $1.92M | 0.1% |
+7,000
| New | +$1.89M |
|
|
GRTS
87
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.92M | 0.1% |
+3,318,093
| New | +$1.86M |
|
88
Alphabet (Google) Class A
GOOGL
$4.33T
| $1.82M | 0.09% |
+11,000
| New | +$1.85M |
|
89
Occidental Petroleum
OXY
$55.9B
| $1.8M | 0.09% |
+35,000
| New | +$2M |
|
90
JFrog
FROG
$10.8B
| $1.77M | 0.09% |
+61,000
| New | +$1.92M |
|
|
OMGA
91
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.61M | 0.08% |
+1,323,530
| New | +$2.11M |
|
92
Natera
NTRA
$46.4B
| $1.6M | 0.08% |
+12,594
| New | +$1.45M |
|
93
Palo Alto Networks
PANW
$297B
| $1.54M | 0.08% |
+9,000
| New | +$1.51M |
|
|
94
PayPal
PYPL
$50.5B
| $1.17M | 0.06% |
+15,000
| New | +$1M |
|
95
Elastic
ESTC
$7.81B
| $998K | 0.05% |
+13,000
| New | +$1.28M |
|
96
Intel
INTC
$513B
| $938K | 0.05% |
+40,000
| New | +$999K |
|
97
Meta Platforms (Facebook)
META
$1.51T
| $859K | 0.04% |
+1,500
| New | +$772K |
|
|
KRON
98
DELISTED
Kronos Bio
KRON
| $843K | 0.04% |
+842,954
| New | +$933K |
|
|
TERN
99
DELISTED
Terns Pharmaceuticals
TERN
| $834K | 0.04% |
+100,000
| New | +$823K |
|
100
Rubrik
RBRK
$18.5B
| $804K | 0.04% |
+25,000
| New | +$828K |
|
Similar funds
SCM
ACM
GCM
VI
BPS
VPC
WWA
OCM
Siren LLC's Q3 2024 Portfolio in Review
Q3 2024 is the first quarter with a 13F filing on record for Siren LLC, which disclosed 112 positions worth $2B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Kymera Therapeutics: 2,969,733 shares worth $141M.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, followed by Technology and Communication Services.
- Siren LLC's largest Q3 2024 buy was Kymera Therapeutics: 2,969,733 shares worth $141M.
- Siren LLC's ten largest holdings make up 41% of its $2B portfolio in Q3 2024.
- Siren LLC disclosed 112 positions in Q3 2024, its first 13F filing on record.
Based on Siren LLC's 13F filing for Q3 2024, filed 13 Nov 2024.